Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 1, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 4, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001982573-26-000002
Filed / recorded
Mar 4, 2026, 12:17 AM UTC
Added to OQRO
Oct 6, 2026, 7:37 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Elanco Animal Health Inc
Issuer CIK
1739104
Ticker
ELAN
Reporting person
Grace Mcardle
Relationship
Officer
Officer title
EVP, MANUFACTURING AND QUALITY
Security
Employee Stock Option (right to buy)
Table
Derivative (Table II)
Transaction date
Mar 1, 2026
Transaction code
A
Shares / units
29,025
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
29,025
Ownership form
Direct
Amendment
No
Footnotes from the filing
Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.